elzonris - tagraxofusp injection, solution
(Tagraxofusp)Stemline Therapeutics, Inc.
Usage: Elzonris treats blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and pediatric patients aged 2 years and older.
Stemline Therapeutics, Inc. drugs
2 results
orserdu - elacestrant tablet, film coated
(Elacestrant)Stemline Therapeutics, Inc.Usage: Orserdu treats ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer in postmenopausal women or adult men whose disease progressed after at least one endocrine therapy. An FDA-authorized test must confirm the ESR1 mutation.